Abstract
(1) To assess the efficacy and safety of recombinant human follicle-stimulating hormone (r-hFSH; follitropin alfa, freeze-dried formulation) in increasing sperm concentration in men with hypogonadotropic hypogonadism (HH). (2) To assess the impact of baseline data on outcome data.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.